Indegene centralized Medical Affairs content strategy and operations across 115+ brands and 8 therapeutic areas—Oncology, Nephrology, Hematology, Bone, Cardiovascular, Neurology, Inflammatory, and Biosimilars Pipeline—for a global pharma spanning US, Canada, EU, JAPAC, LATAM, and MEA. Fragmented operations with multiple AORs caused effort duplication, inefficient TA lead utilization, team silos, poor global-local traceability, redundancies, high costs, and delayed market timelines. Indegene's advanced software unified workflows, eliminated duplication through centralized asset libraries, enabled real-time traceability, optimized resource allocation, and automated reviews, slashing costs and accelerating global deployments.

Join for free to read